By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences today said that it has raised $109 million in a Series F round of financing.

The firm did not disclose the investors in the round, other than Gen-Probe, which recently made a $50 million investment in PacBio. As a result of the investment, Gen-Probe now holds an approximately 7 percent stake in PacBio.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.